eToroTrade IPO stocks the day they listStart on eToro
All companies
Picard Medical Inc logo

Picard Medical Inc

PMI
PublicArchived
Public / ArchivedUnited StatesUSUnited States(NYSE)Best valuation $20.04M1 market

Public listing

Listed· NYSE· Listing market: United StatesUS United States
Listing date
Aug 29, 2025
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available

Sources: sec-harvest, nasdaq

IPO Calendar
IPO Calendar · NYSEIPO
PMI
Price
$0.2000
24h
+9.83%
Valuation
$20.04M
24h volume
$1.29M
Type
IPO
IPO CalendarTrade Picard Medical Inc

Now trading publicly. Buy via a broker — opens in a new tab.

IPO Calendar · updated 1h ago

Picard Medical Inc IPO public float & lock-up

Public float and locked shares extracted from Picard Medical Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.

424B4May 6, 2026
Total shares (FD)
92.04M
Public float
16.67M
Locked
75.38M
IPO raise
Next unlock

Needs review: Could not extract a detailed lock-up release schedule.

Financials

Unprofitable

From SEC filings, latest FY ending Dec 31, 2025 · CIK 0002030617.

Revenue · +12.50% YoY
$4.94M
Net income
-$27M
Gross margin
-4.13%
Cash
$7.45M
Metric202520242023
Revenue$4.94M$4.39M
Gross profit-$204K-$112K
Operating income-$13.26M-$13.71M
Net income-$27M-$21.06M
R&D expense$3.05M$3.38M
Cash & equivalents$7.45M$96K
Total assets$22.55M$12.11M
Total liabilities$18.76M$35.84M
Shareholders' equity$3.79M-$44M-$23.82M

About Picard Medical Inc

Picard Medical is a medical technology company focused on total artificial heart systems through its SynCardia subsidiary.

What the company does

  • Develops, manufactures, and commercializes the SynCardia Total Artificial Heart for patients with advanced or end-stage heart failure.
  • Supports hospital-based and portable driver systems used with total artificial heart therapy.
  • Works in a specialized cardiovascular device market that requires surgical training, clinical support, regulatory compliance, and manufacturing reliability.

Business profile

Picard Medical operates in medical devices, where clinical outcomes, regulatory approvals, physician adoption, reimbursement, and post-implant support are central.

SEC IPO filings

Final prospectus

EDGAR filings resolved from PMI / CIK 0002030617.

Jun 1, 2026Final prospectus0001437749-26-019043
May 20, 2026Filed0001437749-26-017949
424B4424B4
May 6, 2026Final prospectus0001829126-26-004627
May 4, 2026SEC correspondence0001829126-26-004417
May 4, 2026SEC correspondence0001829126-26-004415
S-1/AS-1/A
May 1, 2026Amended0001829126-26-004376
Apr 30, 2026SEC correspondence0001829126-26-004278
Apr 30, 2026SEC correspondence0001829126-26-004277
Apr 27, 2026SEC correspondence0001829126-26-003983
Apr 27, 2026SEC correspondence0001829126-26-003982

Latest Picard Medical Inc IPO news

Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.

Picard Medical Inc IPO — frequently asked questions

When did Picard Medical Inc go public?
Picard Medical Inc completed its IPO on Aug 29, 2025 on NYSE under the ticker PMI and now trades publicly.
Can I buy Picard Medical Inc stock?
Yes — Picard Medical Inc is publicly traded on NYSE as PMI. You can follow its live price, valuation and post-IPO performance above.
What is Picard Medical Inc's valuation?
Picard Medical Inc's most recent valuation tracked here is $20.04M, derived from live market prices.